Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Shim

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
Cancer Research and Treatment|September 12, 2009
Autologous stem cell transplantation using a modified TAM conditioning regimen for clinically aggressive non-Hodgkin's lymphomaSook Hee Hong, Young Seon Hong, In Sook Woo, et al.
BMC Cancer|January 6, 2021
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapySeo Ree Kim, Sang Hoon Chun, Joo Ri Kim, et al.
Journal of Korean Medical Science|March 12, 2014
Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver diseaseWon Ki Hong, Kwang Yong Shim, Soon Koo Baik, et al.
Journal of Cancer|January 6, 2021
A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancerBoram Han, Bum Jun Kim, Hyeong Su Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION StudyMyung-Ju Ahn, Igor Bondarenko, Ewa Kalinka, et al.
Journal of Ginseng Research|October 20, 2018
Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trialSang-Wook Song, Ha-Na Kim, Jae-Yong Shim, et al.
International Journal of Cancer|June 2, 2011
The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivoHun Soon Jung, Ozgur Cem Erkin, Mi Jeong Kwon, et al.
Growth Factors (Chur, Switzerland)|February 26, 2015
L-ascorbic acid 2-phosphate and fibroblast growth factor-2 treatment maintains differentiation potential in bone marrow-derived mesenchymal stem cells through expression of hepatocyte growth factorSung Hae Bae, Hoon Ryu, Ki-Jong Rhee, et al.
Japanese Journal of Clinical Oncology|June 1, 2006
Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancerJae Ho Byun, Myung Ah Lee, Sang Young Roh, et al.
Cancers|October 28, 2023
Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal CancerJi Eun Shin, Ho Jung An, Byoung Yong Shim, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
Cancer Research and Treatment|September 12, 2009
Autologous stem cell transplantation using a modified TAM conditioning regimen for clinically aggressive non-Hodgkin's lymphomaSook Hee Hong, Young Seon Hong, In Sook Woo, et al.
BMC Cancer|January 6, 2021
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapySeo Ree Kim, Sang Hoon Chun, Joo Ri Kim, et al.
Journal of Korean Medical Science|March 12, 2014
Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver diseaseWon Ki Hong, Kwang Yong Shim, Soon Koo Baik, et al.
Journal of Cancer|January 6, 2021
A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancerBoram Han, Bum Jun Kim, Hyeong Su Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION StudyMyung-Ju Ahn, Igor Bondarenko, Ewa Kalinka, et al.
Journal of Ginseng Research|October 20, 2018
Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trialSang-Wook Song, Ha-Na Kim, Jae-Yong Shim, et al.
International Journal of Cancer|June 2, 2011
The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivoHun Soon Jung, Ozgur Cem Erkin, Mi Jeong Kwon, et al.
Growth Factors (Chur, Switzerland)|February 26, 2015
L-ascorbic acid 2-phosphate and fibroblast growth factor-2 treatment maintains differentiation potential in bone marrow-derived mesenchymal stem cells through expression of hepatocyte growth factorSung Hae Bae, Hoon Ryu, Ki-Jong Rhee, et al.
Japanese Journal of Clinical Oncology|June 1, 2006
Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancerJae Ho Byun, Myung Ah Lee, Sang Young Roh, et al.
Cancers|October 28, 2023
Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal CancerJi Eun Shin, Ho Jung An, Byoung Yong Shim, et al.
Pageof 29